Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease

BACKGROUND: Angiotensin converting enzyme inhibitors (ACEi) and angiotensin II receptor antagonists (AIIRA) are considered to be equally effective for patients with diabetic kidney disease (DKD), but renal and not mortality outcomes have usually been considered. OBJECTIVES: To evaluate the benefits...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cochrane Database Syst Rev
Hlavní autoři: Strippoli, Giovanni FM, Bonifati, Carmen, Craig, Maria E, Navaneethan, Sankar D, Craig, Jonathan C
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Ltd 2006
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6956646/
https://ncbi.nlm.nih.gov/pubmed/17054288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD006257
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky